Stopped trial interpretation
Terminated clinical trials are not always clinical trial failures
The first mistake in clinical trial failure analysis is treating every terminated trial as a failed drug or failed biology. The stopped-trial dataset shows why that shortcut is too blunt.
- The current dataset contains 23,452 stopped clinical trial records.
- 16,085 records are terminated, 6,782 are withdrawn, and 585 are suspended.
- Only 1,813 records, or 7.7%, are classified as likely biological failure signals from efficacy/futility or safety language.
- Operational stop reasons are the largest bucket with 12,013 records.
- Other or unclear stop reasons account for 9,534 records, which is why source review still matters.
The short version
A terminated clinical trial is not automatically a failed clinical trial. It means the study stopped before normal completion. The reason can be weak efficacy, safety, enrollment, funding, sponsor strategy, protocol changes, operations, or simply unclear registry language.
That distinction matters because the wrong interpretation can make a sponsor, target, disease area, or modality look worse than the evidence actually supports.
What the stopped-trial dataset shows
Across 23,452 stopped records, operational reasons dominate. There are 12,013 operational stops, compared with 1,096 efficacy/futility stops and 717 safety stops.
That does not mean efficacy and safety failures are rare in absolute terms. It means they are much smaller than the full universe of terminated, withdrawn, and suspended trial records. The useful workflow is to separate status from reason before drawing conclusions.
How I would use this in practice
If I am researching a company or disease area, I would not start by counting all terminated trials as failures. I would first filter down to likely biological signals, then read the actual stop language.
For example, an efficacy/futility stop is much closer to a scientific failure signal than a study stopped for recruitment, logistics, sponsor decision, or an unclear administrative reason.
The practical takeaway
The phrase clinical trial failure is useful, but it needs discipline. A clean failure analysis should say what failed: the intervention, the endpoint, recruitment, financing, operations, or the sponsor's willingness to continue.
That is why the database separates stopped status from classified stop reason. It is not perfect, but it is far better than treating all terminated trials as the same thing.
Stopped trial status mix
| Status | Records |
|---|---|
| Terminated | 16,085 |
| Withdrawn | 6,782 |
| Suspended | 585 |
Stop-reason buckets
| Reason bucket | Records |
|---|---|
| Operational | 12,013 |
| Other/unknown | 9,534 |
| Efficacy/futility | 1,096 |
| Safety | 717 |
| Regulatory | 92 |
Continue from here
FAQ
Is a terminated clinical trial always a failed clinical trial?
No. Terminated status means the study stopped early. The reason may be scientific, operational, strategic, financial, regulatory, or unclear.
Which stopped trials are closest to biological failure signals?
Records classified as efficacy/futility or safety are usually closer to biological failure signals than operational or unclear stops.
Why does this matter for SEO and research?
Because people search for clinical trial failures, but the real analytical value comes from separating stopped status from the reason the study stopped.
Source note: counts are generated from the current ClinicalTrials.gov-derived stopped-trial dataset used by ClinicalTrialFailures.com. These labels are analytical screening signals, not medical advice.